Seraph® Clinical Trial
ExThera Medical is sponsoring a prospective, multi-center, non-randomized European trial for the Seraph® Microbind® Affinity Blood Filter (Seraph). The trial is designed to determine the safety and performance of the Seraph for reducing bacteremia (Staphylococcus aureus or MRSA) in patients on hemodialysis. The study will enroll 15 patients at up to 5 centers in Germany.
Additional details about the study can be obtained by visiting https://clinicaltrials.gov/show/NCT02914132. CinicalTrials.gov Identifier: NCT02914132